nodes	percent_of_prediction	percent_of_DWPC	metapath
Clarithromycin—ABCB1—esophageal cancer	0.527	1	CbGaD
Clarithromycin—SLC22A7—Methotrexate—esophageal cancer	0.0966	0.675	CbGbCtD
Clarithromycin—ABCB1—Cisplatin—esophageal cancer	0.0282	0.197	CbGbCtD
Clarithromycin—ABCB1—Methotrexate—esophageal cancer	0.0183	0.128	CbGbCtD
Clarithromycin—Azithromycin—CYP2A6—esophageal cancer	0.00276	0.328	CrCbGaD
Clarithromycin—Troleandomycin—CYP2A6—esophageal cancer	0.00212	0.252	CrCbGaD
Clarithromycin—Roxithromycin—ABCB1—esophageal cancer	0.00103	0.122	CrCbGaD
Clarithromycin—Azithromycin—ABCB1—esophageal cancer	0.00103	0.122	CrCbGaD
Clarithromycin—Neoplasm—Capecitabine—esophageal cancer	0.000944	0.00507	CcSEcCtD
Clarithromycin—Breast disorder—Cisplatin—esophageal cancer	0.000929	0.00499	CcSEcCtD
Clarithromycin—Aspartate aminotransferase increased—Cisplatin—esophageal cancer	0.000926	0.00497	CcSEcCtD
Clarithromycin—Sleep disorder—Capecitabine—esophageal cancer	0.000876	0.0047	CcSEcCtD
Clarithromycin—Blood alkaline phosphatase increased—Capecitabine—esophageal cancer	0.000871	0.00468	CcSEcCtD
Clarithromycin—Pancreatitis—Cisplatin—esophageal cancer	0.000871	0.00468	CcSEcCtD
Clarithromycin—Hepatic function abnormal—Capecitabine—esophageal cancer	0.000867	0.00465	CcSEcCtD
Clarithromycin—Gastroenteritis—Capecitabine—esophageal cancer	0.000855	0.00459	CcSEcCtD
Clarithromycin—Deafness—Capecitabine—esophageal cancer	0.000847	0.00455	CcSEcCtD
Clarithromycin—Glossitis—Methotrexate—esophageal cancer	0.000843	0.00453	CcSEcCtD
Clarithromycin—Hepatic failure—Capecitabine—esophageal cancer	0.000843	0.00453	CcSEcCtD
Clarithromycin—Atrial fibrillation—Capecitabine—esophageal cancer	0.0008	0.00429	CcSEcCtD
Clarithromycin—Renal impairment—Capecitabine—esophageal cancer	0.000796	0.00427	CcSEcCtD
Clarithromycin—Dermatitis bullous—Capecitabine—esophageal cancer	0.000793	0.00426	CcSEcCtD
Clarithromycin—Troleandomycin—ABCB1—esophageal cancer	0.00079	0.0939	CrCbGaD
Clarithromycin—Purpura—Capecitabine—esophageal cancer	0.000786	0.00422	CcSEcCtD
Clarithromycin—Renal failure—Cisplatin—esophageal cancer	0.000779	0.00418	CcSEcCtD
Clarithromycin—Pulmonary embolism—Methotrexate—esophageal cancer	0.000777	0.00417	CcSEcCtD
Clarithromycin—Stomatitis—Cisplatin—esophageal cancer	0.000772	0.00415	CcSEcCtD
Clarithromycin—Conjunctivitis—Cisplatin—esophageal cancer	0.00077	0.00413	CcSEcCtD
Clarithromycin—Hepatobiliary disease—Cisplatin—esophageal cancer	0.000749	0.00402	CcSEcCtD
Clarithromycin—Vaginal infection—Methotrexate—esophageal cancer	0.000734	0.00394	CcSEcCtD
Clarithromycin—Cardiac arrest—Capecitabine—esophageal cancer	0.000721	0.00387	CcSEcCtD
Clarithromycin—Blood creatinine increased—Capecitabine—esophageal cancer	0.00071	0.00381	CcSEcCtD
Clarithromycin—Neoplasm—Methotrexate—esophageal cancer	0.000703	0.00377	CcSEcCtD
Clarithromycin—Urinary tract disorder—Cisplatin—esophageal cancer	0.000702	0.00377	CcSEcCtD
Clarithromycin—Liver function test abnormal—Capecitabine—esophageal cancer	0.0007	0.00376	CcSEcCtD
Clarithromycin—Connective tissue disorder—Cisplatin—esophageal cancer	0.000699	0.00375	CcSEcCtD
Clarithromycin—Urethral disorder—Cisplatin—esophageal cancer	0.000697	0.00374	CcSEcCtD
Clarithromycin—Erythromycin—ABCB1—esophageal cancer	0.000686	0.0815	CrCbGaD
Clarithromycin—Visual impairment—Cisplatin—esophageal cancer	0.000685	0.00368	CcSEcCtD
Clarithromycin—Breast disorder—Capecitabine—esophageal cancer	0.000685	0.00368	CcSEcCtD
Clarithromycin—Toxic epidermal necrolysis—Capecitabine—esophageal cancer	0.000682	0.00366	CcSEcCtD
Clarithromycin—Aspartate aminotransferase increased—Capecitabine—esophageal cancer	0.000682	0.00366	CcSEcCtD
Clarithromycin—Gastritis—Capecitabine—esophageal cancer	0.000671	0.0036	CcSEcCtD
Clarithromycin—Alanine aminotransferase increased—Capecitabine—esophageal cancer	0.000668	0.00359	CcSEcCtD
Clarithromycin—Eye disorder—Cisplatin—esophageal cancer	0.000665	0.00357	CcSEcCtD
Clarithromycin—Tinnitus—Cisplatin—esophageal cancer	0.000663	0.00356	CcSEcCtD
Clarithromycin—Flushing—Cisplatin—esophageal cancer	0.00066	0.00354	CcSEcCtD
Clarithromycin—Cardiac disorder—Cisplatin—esophageal cancer	0.00066	0.00354	CcSEcCtD
Clarithromycin—Abdominal distension—Capecitabine—esophageal cancer	0.000659	0.00354	CcSEcCtD
Clarithromycin—Asthma—Capecitabine—esophageal cancer	0.000655	0.00352	CcSEcCtD
Clarithromycin—Influenza—Capecitabine—esophageal cancer	0.000655	0.00352	CcSEcCtD
Clarithromycin—Immune system disorder—Cisplatin—esophageal cancer	0.000642	0.00345	CcSEcCtD
Clarithromycin—Mediastinal disorder—Cisplatin—esophageal cancer	0.000641	0.00344	CcSEcCtD
Clarithromycin—Hepatic failure—Methotrexate—esophageal cancer	0.000628	0.00337	CcSEcCtD
Clarithromycin—Malnutrition—Cisplatin—esophageal cancer	0.000619	0.00332	CcSEcCtD
Clarithromycin—Neutropenia—Capecitabine—esophageal cancer	0.000613	0.00329	CcSEcCtD
Clarithromycin—Dysuria—Capecitabine—esophageal cancer	0.000613	0.00329	CcSEcCtD
Clarithromycin—Flatulence—Cisplatin—esophageal cancer	0.00061	0.00327	CcSEcCtD
Clarithromycin—Visual disturbance—Methotrexate—esophageal cancer	0.000595	0.0032	CcSEcCtD
Clarithromycin—Muscle spasms—Cisplatin—esophageal cancer	0.000595	0.0032	CcSEcCtD
Clarithromycin—Pneumonia—Capecitabine—esophageal cancer	0.000587	0.00315	CcSEcCtD
Clarithromycin—Infestation NOS—Capecitabine—esophageal cancer	0.000584	0.00313	CcSEcCtD
Clarithromycin—Infestation—Capecitabine—esophageal cancer	0.000584	0.00313	CcSEcCtD
Clarithromycin—Anaphylactoid reaction—Methotrexate—esophageal cancer	0.000583	0.00313	CcSEcCtD
Clarithromycin—Depression—Capecitabine—esophageal cancer	0.000582	0.00313	CcSEcCtD
Clarithromycin—Tremor—Cisplatin—esophageal cancer	0.00058	0.00311	CcSEcCtD
Clarithromycin—Stevens-Johnson syndrome—Capecitabine—esophageal cancer	0.000579	0.00311	CcSEcCtD
Clarithromycin—Ill-defined disorder—Cisplatin—esophageal cancer	0.000574	0.00308	CcSEcCtD
Clarithromycin—Renal failure—Capecitabine—esophageal cancer	0.000574	0.00308	CcSEcCtD
Clarithromycin—Anaemia—Cisplatin—esophageal cancer	0.000572	0.00307	CcSEcCtD
Clarithromycin—Stomatitis—Capecitabine—esophageal cancer	0.000569	0.00306	CcSEcCtD
Clarithromycin—Jaundice—Capecitabine—esophageal cancer	0.000569	0.00306	CcSEcCtD
Clarithromycin—Conjunctivitis—Capecitabine—esophageal cancer	0.000568	0.00305	CcSEcCtD
Clarithromycin—Malaise—Cisplatin—esophageal cancer	0.000558	0.003	CcSEcCtD
Clarithromycin—Haematuria—Capecitabine—esophageal cancer	0.000557	0.00299	CcSEcCtD
Clarithromycin—Leukopenia—Cisplatin—esophageal cancer	0.000554	0.00297	CcSEcCtD
Clarithromycin—Hepatobiliary disease—Capecitabine—esophageal cancer	0.000552	0.00296	CcSEcCtD
Clarithromycin—Epistaxis—Capecitabine—esophageal cancer	0.000551	0.00296	CcSEcCtD
Clarithromycin—Agranulocytosis—Capecitabine—esophageal cancer	0.000545	0.00293	CcSEcCtD
Clarithromycin—Convulsion—Cisplatin—esophageal cancer	0.000536	0.00288	CcSEcCtD
Clarithromycin—Myalgia—Cisplatin—esophageal cancer	0.000527	0.00283	CcSEcCtD
Clarithromycin—Haemoglobin—Capecitabine—esophageal cancer	0.000527	0.00283	CcSEcCtD
Clarithromycin—Rhinitis—Capecitabine—esophageal cancer	0.000526	0.00282	CcSEcCtD
Clarithromycin—Anxiety—Cisplatin—esophageal cancer	0.000525	0.00282	CcSEcCtD
Clarithromycin—Haemorrhage—Capecitabine—esophageal cancer	0.000524	0.00281	CcSEcCtD
Clarithromycin—Hepatitis—Capecitabine—esophageal cancer	0.000524	0.00281	CcSEcCtD
Clarithromycin—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—esophageal cancer	0.000524	0.00281	CcSEcCtD
Clarithromycin—Liver function test abnormal—Methotrexate—esophageal cancer	0.000521	0.0028	CcSEcCtD
Clarithromycin—Discomfort—Cisplatin—esophageal cancer	0.000521	0.0028	CcSEcCtD
Clarithromycin—Pharyngitis—Capecitabine—esophageal cancer	0.00052	0.00279	CcSEcCtD
Clarithromycin—Urinary tract disorder—Capecitabine—esophageal cancer	0.000518	0.00278	CcSEcCtD
Clarithromycin—Connective tissue disorder—Capecitabine—esophageal cancer	0.000515	0.00277	CcSEcCtD
Clarithromycin—Urethral disorder—Capecitabine—esophageal cancer	0.000514	0.00276	CcSEcCtD
Clarithromycin—Breast disorder—Methotrexate—esophageal cancer	0.00051	0.00274	CcSEcCtD
Clarithromycin—Toxic epidermal necrolysis—Methotrexate—esophageal cancer	0.000508	0.00273	CcSEcCtD
Clarithromycin—Anaphylactic shock—Cisplatin—esophageal cancer	0.000505	0.00271	CcSEcCtD
Clarithromycin—Visual impairment—Capecitabine—esophageal cancer	0.000505	0.00271	CcSEcCtD
Clarithromycin—Infection—Cisplatin—esophageal cancer	0.000502	0.00269	CcSEcCtD
Clarithromycin—Erythema multiforme—Capecitabine—esophageal cancer	0.000496	0.00266	CcSEcCtD
Clarithromycin—Nervous system disorder—Cisplatin—esophageal cancer	0.000496	0.00266	CcSEcCtD
Clarithromycin—Thrombocytopenia—Cisplatin—esophageal cancer	0.000495	0.00266	CcSEcCtD
Clarithromycin—Skin disorder—Cisplatin—esophageal cancer	0.000491	0.00263	CcSEcCtD
Clarithromycin—Eye disorder—Capecitabine—esophageal cancer	0.00049	0.00263	CcSEcCtD
Clarithromycin—Tinnitus—Capecitabine—esophageal cancer	0.000489	0.00262	CcSEcCtD
Clarithromycin—Hyperhidrosis—Cisplatin—esophageal cancer	0.000489	0.00262	CcSEcCtD
Clarithromycin—Asthma—Methotrexate—esophageal cancer	0.000488	0.00262	CcSEcCtD
Clarithromycin—Cardiac disorder—Capecitabine—esophageal cancer	0.000487	0.00261	CcSEcCtD
Clarithromycin—Flushing—Capecitabine—esophageal cancer	0.000487	0.00261	CcSEcCtD
Clarithromycin—Eosinophilia—Methotrexate—esophageal cancer	0.000483	0.00259	CcSEcCtD
Clarithromycin—Anorexia—Cisplatin—esophageal cancer	0.000482	0.00259	CcSEcCtD
Clarithromycin—Pancreatitis—Methotrexate—esophageal cancer	0.000478	0.00257	CcSEcCtD
Clarithromycin—Angiopathy—Capecitabine—esophageal cancer	0.000476	0.00255	CcSEcCtD
Clarithromycin—Immune system disorder—Capecitabine—esophageal cancer	0.000474	0.00254	CcSEcCtD
Clarithromycin—Mediastinal disorder—Capecitabine—esophageal cancer	0.000473	0.00254	CcSEcCtD
Clarithromycin—Chills—Capecitabine—esophageal cancer	0.00047	0.00253	CcSEcCtD
Clarithromycin—Musculoskeletal discomfort—Cisplatin—esophageal cancer	0.00046	0.00247	CcSEcCtD
Clarithromycin—Mental disorder—Capecitabine—esophageal cancer	0.000459	0.00247	CcSEcCtD
Clarithromycin—Malnutrition—Capecitabine—esophageal cancer	0.000456	0.00245	CcSEcCtD
Clarithromycin—Neutropenia—Methotrexate—esophageal cancer	0.000456	0.00245	CcSEcCtD
Clarithromycin—Dysuria—Methotrexate—esophageal cancer	0.000456	0.00245	CcSEcCtD
Clarithromycin—Paraesthesia—Cisplatin—esophageal cancer	0.000454	0.00244	CcSEcCtD
Clarithromycin—Dyspnoea—Cisplatin—esophageal cancer	0.000451	0.00242	CcSEcCtD
Clarithromycin—Flatulence—Capecitabine—esophageal cancer	0.00045	0.00241	CcSEcCtD
Clarithromycin—Dysgeusia—Capecitabine—esophageal cancer	0.000447	0.0024	CcSEcCtD
Clarithromycin—Back pain—Capecitabine—esophageal cancer	0.000441	0.00237	CcSEcCtD
Clarithromycin—Decreased appetite—Cisplatin—esophageal cancer	0.000439	0.00236	CcSEcCtD
Clarithromycin—Muscle spasms—Capecitabine—esophageal cancer	0.000439	0.00236	CcSEcCtD
Clarithromycin—Pneumonia—Methotrexate—esophageal cancer	0.000437	0.00235	CcSEcCtD
Clarithromycin—Gastrointestinal disorder—Cisplatin—esophageal cancer	0.000436	0.00234	CcSEcCtD
Clarithromycin—Infestation NOS—Methotrexate—esophageal cancer	0.000435	0.00233	CcSEcCtD
Clarithromycin—Infestation—Methotrexate—esophageal cancer	0.000435	0.00233	CcSEcCtD
Clarithromycin—Depression—Methotrexate—esophageal cancer	0.000434	0.00233	CcSEcCtD
Clarithromycin—Pain—Cisplatin—esophageal cancer	0.000432	0.00232	CcSEcCtD
Clarithromycin—Stevens-Johnson syndrome—Methotrexate—esophageal cancer	0.000431	0.00231	CcSEcCtD
Clarithromycin—Tremor—Capecitabine—esophageal cancer	0.000428	0.0023	CcSEcCtD
Clarithromycin—Renal failure—Methotrexate—esophageal cancer	0.000427	0.00229	CcSEcCtD
Clarithromycin—Stomatitis—Methotrexate—esophageal cancer	0.000424	0.00227	CcSEcCtD
Clarithromycin—Ill-defined disorder—Capecitabine—esophageal cancer	0.000423	0.00227	CcSEcCtD
Clarithromycin—Conjunctivitis—Methotrexate—esophageal cancer	0.000423	0.00227	CcSEcCtD
Clarithromycin—Anaemia—Capecitabine—esophageal cancer	0.000422	0.00226	CcSEcCtD
Clarithromycin—Feeling abnormal—Cisplatin—esophageal cancer	0.000416	0.00224	CcSEcCtD
Clarithromycin—Haematuria—Methotrexate—esophageal cancer	0.000415	0.00223	CcSEcCtD
Clarithromycin—Malaise—Capecitabine—esophageal cancer	0.000412	0.00221	CcSEcCtD
Clarithromycin—Hepatobiliary disease—Methotrexate—esophageal cancer	0.000411	0.00221	CcSEcCtD
Clarithromycin—Epistaxis—Methotrexate—esophageal cancer	0.00041	0.0022	CcSEcCtD
Clarithromycin—Vertigo—Capecitabine—esophageal cancer	0.00041	0.0022	CcSEcCtD
Clarithromycin—Leukopenia—Capecitabine—esophageal cancer	0.000409	0.00219	CcSEcCtD
Clarithromycin—Agranulocytosis—Methotrexate—esophageal cancer	0.000406	0.00218	CcSEcCtD
Clarithromycin—Palpitations—Capecitabine—esophageal cancer	0.000403	0.00216	CcSEcCtD
Clarithromycin—Loss of consciousness—Capecitabine—esophageal cancer	0.000401	0.00215	CcSEcCtD
Clarithromycin—Body temperature increased—Cisplatin—esophageal cancer	0.000399	0.00214	CcSEcCtD
Clarithromycin—Cough—Capecitabine—esophageal cancer	0.000398	0.00214	CcSEcCtD
Clarithromycin—Haemoglobin—Methotrexate—esophageal cancer	0.000392	0.00211	CcSEcCtD
Clarithromycin—Hepatitis—Methotrexate—esophageal cancer	0.00039	0.00209	CcSEcCtD
Clarithromycin—Haemorrhage—Methotrexate—esophageal cancer	0.00039	0.00209	CcSEcCtD
Clarithromycin—Chest pain—Capecitabine—esophageal cancer	0.000389	0.00209	CcSEcCtD
Clarithromycin—Myalgia—Capecitabine—esophageal cancer	0.000389	0.00209	CcSEcCtD
Clarithromycin—Pharyngitis—Methotrexate—esophageal cancer	0.000387	0.00208	CcSEcCtD
Clarithromycin—Anxiety—Capecitabine—esophageal cancer	0.000387	0.00208	CcSEcCtD
Clarithromycin—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—esophageal cancer	0.000386	0.00207	CcSEcCtD
Clarithromycin—Urinary tract disorder—Methotrexate—esophageal cancer	0.000385	0.00207	CcSEcCtD
Clarithromycin—Discomfort—Capecitabine—esophageal cancer	0.000384	0.00206	CcSEcCtD
Clarithromycin—Urethral disorder—Methotrexate—esophageal cancer	0.000383	0.00205	CcSEcCtD
Clarithromycin—Dry mouth—Capecitabine—esophageal cancer	0.00038	0.00204	CcSEcCtD
Clarithromycin—Visual impairment—Methotrexate—esophageal cancer	0.000376	0.00202	CcSEcCtD
Clarithromycin—Confusional state—Capecitabine—esophageal cancer	0.000376	0.00202	CcSEcCtD
Clarithromycin—Hypersensitivity—Cisplatin—esophageal cancer	0.000372	0.002	CcSEcCtD
Clarithromycin—Infection—Capecitabine—esophageal cancer	0.00037	0.00199	CcSEcCtD
Clarithromycin—Erythema multiforme—Methotrexate—esophageal cancer	0.000369	0.00198	CcSEcCtD
Clarithromycin—Nervous system disorder—Capecitabine—esophageal cancer	0.000365	0.00196	CcSEcCtD
Clarithromycin—Eye disorder—Methotrexate—esophageal cancer	0.000365	0.00196	CcSEcCtD
Clarithromycin—Thrombocytopenia—Capecitabine—esophageal cancer	0.000365	0.00196	CcSEcCtD
Clarithromycin—Tinnitus—Methotrexate—esophageal cancer	0.000364	0.00195	CcSEcCtD
Clarithromycin—Asthenia—Cisplatin—esophageal cancer	0.000363	0.00195	CcSEcCtD
Clarithromycin—Cardiac disorder—Methotrexate—esophageal cancer	0.000362	0.00194	CcSEcCtD
Clarithromycin—Skin disorder—Capecitabine—esophageal cancer	0.000362	0.00194	CcSEcCtD
Clarithromycin—Hyperhidrosis—Capecitabine—esophageal cancer	0.00036	0.00193	CcSEcCtD
Clarithromycin—Anorexia—Capecitabine—esophageal cancer	0.000355	0.00191	CcSEcCtD
Clarithromycin—Angiopathy—Methotrexate—esophageal cancer	0.000354	0.0019	CcSEcCtD
Clarithromycin—Immune system disorder—Methotrexate—esophageal cancer	0.000353	0.00189	CcSEcCtD
Clarithromycin—Mediastinal disorder—Methotrexate—esophageal cancer	0.000352	0.00189	CcSEcCtD
Clarithromycin—Chills—Methotrexate—esophageal cancer	0.00035	0.00188	CcSEcCtD
Clarithromycin—Diarrhoea—Cisplatin—esophageal cancer	0.000346	0.00186	CcSEcCtD
Clarithromycin—Mental disorder—Methotrexate—esophageal cancer	0.000342	0.00184	CcSEcCtD
Clarithromycin—Malnutrition—Methotrexate—esophageal cancer	0.00034	0.00182	CcSEcCtD
Clarithromycin—Musculoskeletal discomfort—Capecitabine—esophageal cancer	0.000339	0.00182	CcSEcCtD
Clarithromycin—Insomnia—Capecitabine—esophageal cancer	0.000337	0.00181	CcSEcCtD
Clarithromycin—Paraesthesia—Capecitabine—esophageal cancer	0.000334	0.0018	CcSEcCtD
Clarithromycin—Dysgeusia—Methotrexate—esophageal cancer	0.000333	0.00179	CcSEcCtD
Clarithromycin—Dyspnoea—Capecitabine—esophageal cancer	0.000332	0.00178	CcSEcCtD
Clarithromycin—Back pain—Methotrexate—esophageal cancer	0.000329	0.00176	CcSEcCtD
Clarithromycin—Dyspepsia—Capecitabine—esophageal cancer	0.000328	0.00176	CcSEcCtD
Clarithromycin—Decreased appetite—Capecitabine—esophageal cancer	0.000324	0.00174	CcSEcCtD
Clarithromycin—Gastrointestinal disorder—Capecitabine—esophageal cancer	0.000322	0.00173	CcSEcCtD
Clarithromycin—Vomiting—Cisplatin—esophageal cancer	0.000321	0.00172	CcSEcCtD
Clarithromycin—Fatigue—Capecitabine—esophageal cancer	0.000321	0.00172	CcSEcCtD
Clarithromycin—Rash—Cisplatin—esophageal cancer	0.000319	0.00171	CcSEcCtD
Clarithromycin—Pain—Capecitabine—esophageal cancer	0.000319	0.00171	CcSEcCtD
Clarithromycin—Constipation—Capecitabine—esophageal cancer	0.000319	0.00171	CcSEcCtD
Clarithromycin—Dermatitis—Cisplatin—esophageal cancer	0.000318	0.00171	CcSEcCtD
Clarithromycin—Ill-defined disorder—Methotrexate—esophageal cancer	0.000315	0.00169	CcSEcCtD
Clarithromycin—Anaemia—Methotrexate—esophageal cancer	0.000314	0.00169	CcSEcCtD
Clarithromycin—Feeling abnormal—Capecitabine—esophageal cancer	0.000307	0.00165	CcSEcCtD
Clarithromycin—Malaise—Methotrexate—esophageal cancer	0.000306	0.00164	CcSEcCtD
Clarithromycin—Vertigo—Methotrexate—esophageal cancer	0.000305	0.00164	CcSEcCtD
Clarithromycin—Gastrointestinal pain—Capecitabine—esophageal cancer	0.000305	0.00163	CcSEcCtD
Clarithromycin—Leukopenia—Methotrexate—esophageal cancer	0.000304	0.00163	CcSEcCtD
Clarithromycin—Nausea—Cisplatin—esophageal cancer	0.0003	0.00161	CcSEcCtD
Clarithromycin—Cough—Methotrexate—esophageal cancer	0.000296	0.00159	CcSEcCtD
Clarithromycin—Urticaria—Capecitabine—esophageal cancer	0.000296	0.00159	CcSEcCtD
Clarithromycin—Abdominal pain—Capecitabine—esophageal cancer	0.000294	0.00158	CcSEcCtD
Clarithromycin—Body temperature increased—Capecitabine—esophageal cancer	0.000294	0.00158	CcSEcCtD
Clarithromycin—Convulsion—Methotrexate—esophageal cancer	0.000294	0.00158	CcSEcCtD
Clarithromycin—Myalgia—Methotrexate—esophageal cancer	0.000289	0.00155	CcSEcCtD
Clarithromycin—Chest pain—Methotrexate—esophageal cancer	0.000289	0.00155	CcSEcCtD
Clarithromycin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—esophageal cancer	0.000287	0.00154	CcSEcCtD
Clarithromycin—Discomfort—Methotrexate—esophageal cancer	0.000286	0.00153	CcSEcCtD
Clarithromycin—Confusional state—Methotrexate—esophageal cancer	0.00028	0.0015	CcSEcCtD
Clarithromycin—Anaphylactic shock—Methotrexate—esophageal cancer	0.000277	0.00149	CcSEcCtD
Clarithromycin—Infection—Methotrexate—esophageal cancer	0.000275	0.00148	CcSEcCtD
Clarithromycin—Hypersensitivity—Capecitabine—esophageal cancer	0.000274	0.00147	CcSEcCtD
Clarithromycin—Nervous system disorder—Methotrexate—esophageal cancer	0.000272	0.00146	CcSEcCtD
Clarithromycin—Thrombocytopenia—Methotrexate—esophageal cancer	0.000272	0.00146	CcSEcCtD
Clarithromycin—Skin disorder—Methotrexate—esophageal cancer	0.000269	0.00145	CcSEcCtD
Clarithromycin—Hyperhidrosis—Methotrexate—esophageal cancer	0.000268	0.00144	CcSEcCtD
Clarithromycin—Asthenia—Capecitabine—esophageal cancer	0.000267	0.00143	CcSEcCtD
Clarithromycin—Anorexia—Methotrexate—esophageal cancer	0.000264	0.00142	CcSEcCtD
Clarithromycin—Pruritus—Capecitabine—esophageal cancer	0.000264	0.00141	CcSEcCtD
Clarithromycin—Diarrhoea—Capecitabine—esophageal cancer	0.000255	0.00137	CcSEcCtD
Clarithromycin—Musculoskeletal discomfort—Methotrexate—esophageal cancer	0.000253	0.00136	CcSEcCtD
Clarithromycin—Insomnia—Methotrexate—esophageal cancer	0.000251	0.00135	CcSEcCtD
Clarithromycin—Paraesthesia—Methotrexate—esophageal cancer	0.000249	0.00134	CcSEcCtD
Clarithromycin—Dyspnoea—Methotrexate—esophageal cancer	0.000247	0.00133	CcSEcCtD
Clarithromycin—Somnolence—Methotrexate—esophageal cancer	0.000247	0.00132	CcSEcCtD
Clarithromycin—Dizziness—Capecitabine—esophageal cancer	0.000246	0.00132	CcSEcCtD
Clarithromycin—Dyspepsia—Methotrexate—esophageal cancer	0.000244	0.00131	CcSEcCtD
Clarithromycin—Decreased appetite—Methotrexate—esophageal cancer	0.000241	0.00129	CcSEcCtD
Clarithromycin—Gastrointestinal disorder—Methotrexate—esophageal cancer	0.000239	0.00128	CcSEcCtD
Clarithromycin—Fatigue—Methotrexate—esophageal cancer	0.000239	0.00128	CcSEcCtD
Clarithromycin—Pain—Methotrexate—esophageal cancer	0.000237	0.00127	CcSEcCtD
Clarithromycin—Vomiting—Capecitabine—esophageal cancer	0.000237	0.00127	CcSEcCtD
Clarithromycin—Rash—Capecitabine—esophageal cancer	0.000235	0.00126	CcSEcCtD
Clarithromycin—Dermatitis—Capecitabine—esophageal cancer	0.000235	0.00126	CcSEcCtD
Clarithromycin—Headache—Capecitabine—esophageal cancer	0.000233	0.00125	CcSEcCtD
Clarithromycin—Feeling abnormal—Methotrexate—esophageal cancer	0.000229	0.00123	CcSEcCtD
Clarithromycin—Gastrointestinal pain—Methotrexate—esophageal cancer	0.000227	0.00122	CcSEcCtD
Clarithromycin—Nausea—Capecitabine—esophageal cancer	0.000221	0.00119	CcSEcCtD
Clarithromycin—Urticaria—Methotrexate—esophageal cancer	0.00022	0.00118	CcSEcCtD
Clarithromycin—Abdominal pain—Methotrexate—esophageal cancer	0.000219	0.00118	CcSEcCtD
Clarithromycin—Body temperature increased—Methotrexate—esophageal cancer	0.000219	0.00118	CcSEcCtD
Clarithromycin—Hypersensitivity—Methotrexate—esophageal cancer	0.000204	0.0011	CcSEcCtD
Clarithromycin—Asthenia—Methotrexate—esophageal cancer	0.000199	0.00107	CcSEcCtD
Clarithromycin—Pruritus—Methotrexate—esophageal cancer	0.000196	0.00105	CcSEcCtD
Clarithromycin—Diarrhoea—Methotrexate—esophageal cancer	0.00019	0.00102	CcSEcCtD
Clarithromycin—Dizziness—Methotrexate—esophageal cancer	0.000183	0.000984	CcSEcCtD
Clarithromycin—Vomiting—Methotrexate—esophageal cancer	0.000176	0.000946	CcSEcCtD
Clarithromycin—Rash—Methotrexate—esophageal cancer	0.000175	0.000938	CcSEcCtD
Clarithromycin—Dermatitis—Methotrexate—esophageal cancer	0.000175	0.000938	CcSEcCtD
Clarithromycin—Headache—Methotrexate—esophageal cancer	0.000174	0.000932	CcSEcCtD
Clarithromycin—Nausea—Methotrexate—esophageal cancer	0.000165	0.000884	CcSEcCtD
Clarithromycin—CYP3A7—Metabolism—CA1—esophageal cancer	9.62e-05	0.000712	CbGpPWpGaD
Clarithromycin—CYP3A7—Metabolism—SLC10A2—esophageal cancer	9.62e-05	0.000712	CbGpPWpGaD
Clarithromycin—CYP1A2—Metapathway biotransformation—CYP1B1—esophageal cancer	9.61e-05	0.000712	CbGpPWpGaD
Clarithromycin—ABCB1—Integrated Pancreatic Cancer Pathway—ABL1—esophageal cancer	9.55e-05	0.000707	CbGpPWpGaD
Clarithromycin—ABCB1—Transmembrane transport of small molecules—AQP3—esophageal cancer	9.52e-05	0.000705	CbGpPWpGaD
Clarithromycin—CYP3A4—Biological oxidations—GSTT1—esophageal cancer	9.44e-05	0.000699	CbGpPWpGaD
Clarithromycin—CYP1A2—Metabolism of lipids and lipoproteins—SLC10A2—esophageal cancer	9.4e-05	0.000696	CbGpPWpGaD
Clarithromycin—CYP3A4—Biological oxidations—CYP2A6—esophageal cancer	9.33e-05	0.000691	CbGpPWpGaD
Clarithromycin—ABCB1—Integrated Pancreatic Cancer Pathway—SMAD4—esophageal cancer	9.25e-05	0.000685	CbGpPWpGaD
Clarithromycin—CYP1A2—Biological oxidations—CYP19A1—esophageal cancer	9.16e-05	0.000679	CbGpPWpGaD
Clarithromycin—CYP1A2—Aryl Hydrocarbon Receptor—MYC—esophageal cancer	9.15e-05	0.000677	CbGpPWpGaD
Clarithromycin—ABCB1—Transmembrane transport of small molecules—ATP4A—esophageal cancer	9.13e-05	0.000676	CbGpPWpGaD
Clarithromycin—ABCB1—Transmembrane transport of small molecules—SLC30A7—esophageal cancer	9.13e-05	0.000676	CbGpPWpGaD
Clarithromycin—CYP1A2—Metapathway biotransformation—CYP19A1—esophageal cancer	9.04e-05	0.000669	CbGpPWpGaD
Clarithromycin—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—esophageal cancer	8.94e-05	0.000662	CbGpPWpGaD
Clarithromycin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—esophageal cancer	8.94e-05	0.000662	CbGpPWpGaD
Clarithromycin—CYP3A4—Biological oxidations—PTGS1—esophageal cancer	8.85e-05	0.000655	CbGpPWpGaD
Clarithromycin—CYP3A7—Metabolism—CA2—esophageal cancer	8.8e-05	0.000651	CbGpPWpGaD
Clarithromycin—ABCB1—Integrated Pancreatic Cancer Pathway—BAX—esophageal cancer	8.75e-05	0.000648	CbGpPWpGaD
Clarithromycin—CYP3A7—Metabolism—PLCE1—esophageal cancer	8.18e-05	0.000605	CbGpPWpGaD
Clarithromycin—CYP3A7—Metabolism—ADH7—esophageal cancer	8.18e-05	0.000605	CbGpPWpGaD
Clarithromycin—CYP3A5—Metabolism—BLVRB—esophageal cancer	8.18e-05	0.000605	CbGpPWpGaD
Clarithromycin—CYP3A5—Metabolism—SLC52A3—esophageal cancer	8.18e-05	0.000605	CbGpPWpGaD
Clarithromycin—CYP2C19—Metabolism of lipids and lipoproteins—ALOX15—esophageal cancer	8.15e-05	0.000604	CbGpPWpGaD
Clarithromycin—SLC22A7—Transmembrane transport of small molecules—CREBBP—esophageal cancer	7.68e-05	0.000569	CbGpPWpGaD
Clarithromycin—CYP3A4—Biological oxidations—CYP1B1—esophageal cancer	7.52e-05	0.000557	CbGpPWpGaD
Clarithromycin—CYP3A4—Metapathway biotransformation—CYP1B1—esophageal cancer	7.42e-05	0.000549	CbGpPWpGaD
Clarithromycin—CYP3A7—Metabolism—ADH1B—esophageal cancer	7.17e-05	0.000531	CbGpPWpGaD
Clarithromycin—CYP2C19—Metabolism of lipids and lipoproteins—CRABP1—esophageal cancer	7.11e-05	0.000527	CbGpPWpGaD
Clarithromycin—CYP3A4—Biological oxidations—CYP19A1—esophageal cancer	7.07e-05	0.000524	CbGpPWpGaD
Clarithromycin—CYP3A4—Metapathway biotransformation—CYP19A1—esophageal cancer	6.98e-05	0.000517	CbGpPWpGaD
Clarithromycin—CYP3A5—Metabolism—CA1—esophageal cancer	6.95e-05	0.000515	CbGpPWpGaD
Clarithromycin—CYP3A5—Metabolism—SLC10A2—esophageal cancer	6.95e-05	0.000515	CbGpPWpGaD
Clarithromycin—ABCB1—Transmembrane transport of small molecules—ABCC2—esophageal cancer	6.92e-05	0.000512	CbGpPWpGaD
Clarithromycin—CYP3A7—Metabolism—TYMP—esophageal cancer	6.85e-05	0.000507	CbGpPWpGaD
Clarithromycin—CYP3A7—Metabolism—CYP26A1—esophageal cancer	6.67e-05	0.000494	CbGpPWpGaD
Clarithromycin—CYP3A7—Metabolism—ALOX15—esophageal cancer	6.5e-05	0.000481	CbGpPWpGaD
Clarithromycin—CYP3A5—Metabolism—CA2—esophageal cancer	6.36e-05	0.000471	CbGpPWpGaD
Clarithromycin—CYP1A2—Metabolism of lipids and lipoproteins—ALOX15—esophageal cancer	6.35e-05	0.00047	CbGpPWpGaD
Clarithromycin—CYP2C19—Metabolism—BLVRB—esophageal cancer	6.32e-05	0.000468	CbGpPWpGaD
Clarithromycin—CYP2C19—Metabolism—SLC52A3—esophageal cancer	6.32e-05	0.000468	CbGpPWpGaD
Clarithromycin—ABCB1—Transmembrane transport of small molecules—GNG7—esophageal cancer	6.28e-05	0.000465	CbGpPWpGaD
Clarithromycin—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—esophageal cancer	6.21e-05	0.00046	CbGpPWpGaD
Clarithromycin—CYP3A7—Metabolism—GSTO1—esophageal cancer	6.2e-05	0.000459	CbGpPWpGaD
Clarithromycin—CYP3A7—Metabolism—TPI1—esophageal cancer	6.2e-05	0.000459	CbGpPWpGaD
Clarithromycin—ABCB1—Integrated Pancreatic Cancer Pathway—CREBBP—esophageal cancer	6.18e-05	0.000458	CbGpPWpGaD
Clarithromycin—ABCB1—Metabolism—SLC52A3—esophageal cancer	6.17e-05	0.000457	CbGpPWpGaD
Clarithromycin—ABCB1—Metabolism—BLVRB—esophageal cancer	6.17e-05	0.000457	CbGpPWpGaD
Clarithromycin—CYP3A7—Metabolism—ALDOB—esophageal cancer	5.94e-05	0.00044	CbGpPWpGaD
Clarithromycin—CYP3A5—Metabolism—PLCE1—esophageal cancer	5.91e-05	0.000438	CbGpPWpGaD
Clarithromycin—CYP3A5—Metabolism—ADH7—esophageal cancer	5.91e-05	0.000438	CbGpPWpGaD
Clarithromycin—CYP3A7—Metabolism—GAPDH—esophageal cancer	5.72e-05	0.000423	CbGpPWpGaD
Clarithromycin—CYP3A7—Metabolism—CRABP1—esophageal cancer	5.67e-05	0.00042	CbGpPWpGaD
Clarithromycin—CYP2C19—Metabolism of lipids and lipoproteins—PTGS1—esophageal cancer	5.65e-05	0.000418	CbGpPWpGaD
Clarithromycin—CYP1A2—Metabolism of lipids and lipoproteins—CRABP1—esophageal cancer	5.54e-05	0.00041	CbGpPWpGaD
Clarithromycin—CYP3A7—Metabolism—GNG7—esophageal cancer	5.39e-05	0.000399	CbGpPWpGaD
Clarithromycin—CYP2C19—Metabolism—SLC10A2—esophageal cancer	5.37e-05	0.000398	CbGpPWpGaD
Clarithromycin—CYP2C19—Metabolism—CA1—esophageal cancer	5.37e-05	0.000398	CbGpPWpGaD
Clarithromycin—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—esophageal cancer	5.33e-05	0.000394	CbGpPWpGaD
Clarithromycin—ABCB1—Metabolism—CA1—esophageal cancer	5.25e-05	0.000388	CbGpPWpGaD
Clarithromycin—ABCB1—Metabolism—SLC10A2—esophageal cancer	5.25e-05	0.000388	CbGpPWpGaD
Clarithromycin—CYP3A5—Metabolism—ADH1B—esophageal cancer	5.18e-05	0.000384	CbGpPWpGaD
Clarithromycin—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—esophageal cancer	5.18e-05	0.000383	CbGpPWpGaD
Clarithromycin—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—esophageal cancer	5.06e-05	0.000375	CbGpPWpGaD
Clarithromycin—CYP3A7—Metabolism—ALDH2—esophageal cancer	5.05e-05	0.000374	CbGpPWpGaD
Clarithromycin—CYP3A5—Metabolism—TYMP—esophageal cancer	4.95e-05	0.000367	CbGpPWpGaD
Clarithromycin—CYP1A2—Metabolism—SLC52A3—esophageal cancer	4.92e-05	0.000365	CbGpPWpGaD
Clarithromycin—CYP1A2—Metabolism—BLVRB—esophageal cancer	4.92e-05	0.000365	CbGpPWpGaD
Clarithromycin—CYP2C19—Metabolism—CA2—esophageal cancer	4.92e-05	0.000364	CbGpPWpGaD
Clarithromycin—CYP3A5—Metabolism—CYP26A1—esophageal cancer	4.82e-05	0.000357	CbGpPWpGaD
Clarithromycin—CYP3A7—Metabolism—GSTT1—esophageal cancer	4.8e-05	0.000356	CbGpPWpGaD
Clarithromycin—CYP2C19—Metabolism of lipids and lipoproteins—CYP1B1—esophageal cancer	4.8e-05	0.000356	CbGpPWpGaD
Clarithromycin—ABCB1—Metabolism—CA2—esophageal cancer	4.8e-05	0.000355	CbGpPWpGaD
Clarithromycin—CYP3A7—Metabolism—CYP2A6—esophageal cancer	4.75e-05	0.000352	CbGpPWpGaD
Clarithromycin—CYP3A5—Metabolism—ALOX15—esophageal cancer	4.7e-05	0.000348	CbGpPWpGaD
Clarithromycin—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—esophageal cancer	4.57e-05	0.000339	CbGpPWpGaD
Clarithromycin—CYP2C19—Metabolism—ADH7—esophageal cancer	4.57e-05	0.000338	CbGpPWpGaD
Clarithromycin—CYP2C19—Metabolism—PLCE1—esophageal cancer	4.57e-05	0.000338	CbGpPWpGaD
Clarithromycin—CYP2C19—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	4.52e-05	0.000334	CbGpPWpGaD
Clarithromycin—CYP3A7—Metabolism—PTGS1—esophageal cancer	4.5e-05	0.000333	CbGpPWpGaD
Clarithromycin—CYP3A7—Metabolism—ENO1—esophageal cancer	4.5e-05	0.000333	CbGpPWpGaD
Clarithromycin—CYP3A5—Metabolism—TPI1—esophageal cancer	4.48e-05	0.000332	CbGpPWpGaD
Clarithromycin—CYP3A5—Metabolism—GSTO1—esophageal cancer	4.48e-05	0.000332	CbGpPWpGaD
Clarithromycin—ABCB1—Metabolism—ADH7—esophageal cancer	4.46e-05	0.00033	CbGpPWpGaD
Clarithromycin—ABCB1—Metabolism—PLCE1—esophageal cancer	4.46e-05	0.00033	CbGpPWpGaD
Clarithromycin—CYP3A7—Metabolism—PSME1—esophageal cancer	4.44e-05	0.000329	CbGpPWpGaD
Clarithromycin—CYP3A7—Metabolism—PSME2—esophageal cancer	4.44e-05	0.000329	CbGpPWpGaD
Clarithromycin—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—esophageal cancer	4.42e-05	0.000328	CbGpPWpGaD
Clarithromycin—CYP1A2—Metabolism of lipids and lipoproteins—PTGS1—esophageal cancer	4.4e-05	0.000326	CbGpPWpGaD
Clarithromycin—CYP3A5—Metabolism—ALDOB—esophageal cancer	4.29e-05	0.000318	CbGpPWpGaD
Clarithromycin—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—esophageal cancer	4.21e-05	0.000312	CbGpPWpGaD
Clarithromycin—CYP1A2—Metabolism—CA1—esophageal cancer	4.19e-05	0.00031	CbGpPWpGaD
Clarithromycin—CYP1A2—Metabolism—SLC10A2—esophageal cancer	4.19e-05	0.00031	CbGpPWpGaD
Clarithromycin—CYP3A5—Metabolism—GAPDH—esophageal cancer	4.13e-05	0.000306	CbGpPWpGaD
Clarithromycin—CYP3A5—Metabolism—CRABP1—esophageal cancer	4.1e-05	0.000303	CbGpPWpGaD
Clarithromycin—CYP2C19—Metabolism—ADH1B—esophageal cancer	4.01e-05	0.000297	CbGpPWpGaD
Clarithromycin—ABCB1—Metabolism—ADH1B—esophageal cancer	3.91e-05	0.00029	CbGpPWpGaD
Clarithromycin—CYP3A5—Metabolism—GNG7—esophageal cancer	3.9e-05	0.000289	CbGpPWpGaD
Clarithromycin—CYP1A2—Metabolism—CA2—esophageal cancer	3.83e-05	0.000284	CbGpPWpGaD
Clarithromycin—CYP2C19—Metabolism—TYMP—esophageal cancer	3.83e-05	0.000284	CbGpPWpGaD
Clarithromycin—CYP3A7—Metabolism—CYP1B1—esophageal cancer	3.83e-05	0.000283	CbGpPWpGaD
Clarithromycin—ABCB1—Transmembrane transport of small molecules—HMOX1—esophageal cancer	3.83e-05	0.000283	CbGpPWpGaD
Clarithromycin—CYP3A4—Metabolism—SLC52A3—esophageal cancer	3.8e-05	0.000281	CbGpPWpGaD
Clarithromycin—CYP3A4—Metabolism—BLVRB—esophageal cancer	3.8e-05	0.000281	CbGpPWpGaD
Clarithromycin—CYP1A2—Metabolism of lipids and lipoproteins—CYP1B1—esophageal cancer	3.74e-05	0.000277	CbGpPWpGaD
Clarithromycin—ABCB1—Metabolism—TYMP—esophageal cancer	3.74e-05	0.000277	CbGpPWpGaD
Clarithromycin—CYP2C19—Metabolism—CYP26A1—esophageal cancer	3.73e-05	0.000276	CbGpPWpGaD
Clarithromycin—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—esophageal cancer	3.67e-05	0.000272	CbGpPWpGaD
Clarithromycin—CYP3A5—Metabolism—ALDH2—esophageal cancer	3.65e-05	0.00027	CbGpPWpGaD
Clarithromycin—ABCB1—Metabolism—CYP26A1—esophageal cancer	3.64e-05	0.000269	CbGpPWpGaD
Clarithromycin—CYP2C19—Metabolism—ALOX15—esophageal cancer	3.63e-05	0.000269	CbGpPWpGaD
Clarithromycin—CYP3A7—Metabolism—CYP19A1—esophageal cancer	3.6e-05	0.000267	CbGpPWpGaD
Clarithromycin—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—esophageal cancer	3.59e-05	0.000266	CbGpPWpGaD
Clarithromycin—CYP1A2—Metabolism—PLCE1—esophageal cancer	3.56e-05	0.000264	CbGpPWpGaD
Clarithromycin—CYP1A2—Metabolism—ADH7—esophageal cancer	3.56e-05	0.000264	CbGpPWpGaD
Clarithromycin—ABCB1—Metabolism—ALOX15—esophageal cancer	3.54e-05	0.000262	CbGpPWpGaD
Clarithromycin—CYP1A2—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	3.52e-05	0.000261	CbGpPWpGaD
Clarithromycin—CYP3A5—Metabolism—GSTT1—esophageal cancer	3.47e-05	0.000257	CbGpPWpGaD
Clarithromycin—CYP2C19—Metabolism—GSTO1—esophageal cancer	3.46e-05	0.000256	CbGpPWpGaD
Clarithromycin—CYP2C19—Metabolism—TPI1—esophageal cancer	3.46e-05	0.000256	CbGpPWpGaD
Clarithromycin—CYP3A5—Metabolism—CYP2A6—esophageal cancer	3.43e-05	0.000254	CbGpPWpGaD
Clarithromycin—ABCB1—Metabolism—TPI1—esophageal cancer	3.38e-05	0.00025	CbGpPWpGaD
Clarithromycin—ABCB1—Metabolism—GSTO1—esophageal cancer	3.38e-05	0.00025	CbGpPWpGaD
Clarithromycin—CYP2C19—Metabolism—ALDOB—esophageal cancer	3.32e-05	0.000246	CbGpPWpGaD
Clarithromycin—CYP3A7—Metabolism—HMOX1—esophageal cancer	3.28e-05	0.000243	CbGpPWpGaD
Clarithromycin—CYP3A5—Metabolism—ENO1—esophageal cancer	3.25e-05	0.000241	CbGpPWpGaD
Clarithromycin—CYP3A5—Metabolism—PTGS1—esophageal cancer	3.25e-05	0.000241	CbGpPWpGaD
Clarithromycin—ABCB1—Metabolism—ALDOB—esophageal cancer	3.24e-05	0.00024	CbGpPWpGaD
Clarithromycin—CYP3A4—Metabolism—SLC10A2—esophageal cancer	3.23e-05	0.000239	CbGpPWpGaD
Clarithromycin—CYP3A4—Metabolism—CA1—esophageal cancer	3.23e-05	0.000239	CbGpPWpGaD
Clarithromycin—CYP3A5—Metabolism—PSME2—esophageal cancer	3.21e-05	0.000237	CbGpPWpGaD
Clarithromycin—CYP3A5—Metabolism—PSME1—esophageal cancer	3.21e-05	0.000237	CbGpPWpGaD
Clarithromycin—CYP2C19—Metabolism—GAPDH—esophageal cancer	3.2e-05	0.000237	CbGpPWpGaD
Clarithromycin—CYP2C19—Metabolism—CRABP1—esophageal cancer	3.17e-05	0.000235	CbGpPWpGaD
Clarithromycin—CYP3A7—Metabolism—ABCB1—esophageal cancer	3.15e-05	0.000233	CbGpPWpGaD
Clarithromycin—CYP1A2—Metabolism—ADH1B—esophageal cancer	3.12e-05	0.000231	CbGpPWpGaD
Clarithromycin—ABCB1—Metabolism—GAPDH—esophageal cancer	3.12e-05	0.000231	CbGpPWpGaD
Clarithromycin—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—esophageal cancer	3.11e-05	0.000231	CbGpPWpGaD
Clarithromycin—ABCB1—Metabolism—CRABP1—esophageal cancer	3.09e-05	0.000229	CbGpPWpGaD
Clarithromycin—CYP2C19—Metabolism—GNG7—esophageal cancer	3.01e-05	0.000223	CbGpPWpGaD
Clarithromycin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—esophageal cancer	3.01e-05	0.000223	CbGpPWpGaD
Clarithromycin—CYP1A2—Metabolism—TYMP—esophageal cancer	2.98e-05	0.000221	CbGpPWpGaD
Clarithromycin—CYP3A4—Metabolism—CA2—esophageal cancer	2.96e-05	0.000219	CbGpPWpGaD
Clarithromycin—ABCB1—Metabolism—GNG7—esophageal cancer	2.94e-05	0.000218	CbGpPWpGaD
Clarithromycin—CYP1A2—Metabolism—CYP26A1—esophageal cancer	2.9e-05	0.000215	CbGpPWpGaD
Clarithromycin—CYP1A2—Metabolism—ALOX15—esophageal cancer	2.83e-05	0.000209	CbGpPWpGaD
Clarithromycin—CYP2C19—Metabolism—ALDH2—esophageal cancer	2.82e-05	0.000209	CbGpPWpGaD
Clarithromycin—CYP3A5—Metabolism—CYP1B1—esophageal cancer	2.77e-05	0.000205	CbGpPWpGaD
Clarithromycin—ABCB1—Metabolism—ALDH2—esophageal cancer	2.76e-05	0.000204	CbGpPWpGaD
Clarithromycin—CYP3A4—Metabolism—PLCE1—esophageal cancer	2.75e-05	0.000203	CbGpPWpGaD
Clarithromycin—CYP3A4—Metabolism—ADH7—esophageal cancer	2.75e-05	0.000203	CbGpPWpGaD
Clarithromycin—CYP1A2—Metabolism—TPI1—esophageal cancer	2.7e-05	0.0002	CbGpPWpGaD
Clarithromycin—CYP1A2—Metabolism—GSTO1—esophageal cancer	2.7e-05	0.0002	CbGpPWpGaD
Clarithromycin—CYP2C19—Metabolism—GSTT1—esophageal cancer	2.69e-05	0.000199	CbGpPWpGaD
Clarithromycin—CYP2C19—Metabolism—CYP2A6—esophageal cancer	2.65e-05	0.000197	CbGpPWpGaD
Clarithromycin—CYP2C19—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	2.64e-05	0.000196	CbGpPWpGaD
Clarithromycin—ABCB1—Metabolism—GSTT1—esophageal cancer	2.62e-05	0.000194	CbGpPWpGaD
Clarithromycin—CYP3A5—Metabolism—CYP19A1—esophageal cancer	2.6e-05	0.000193	CbGpPWpGaD
Clarithromycin—ABCB1—Metabolism—CYP2A6—esophageal cancer	2.59e-05	0.000192	CbGpPWpGaD
Clarithromycin—CYP1A2—Metabolism—ALDOB—esophageal cancer	2.59e-05	0.000192	CbGpPWpGaD
Clarithromycin—CYP2C19—Metabolism—ENO1—esophageal cancer	2.52e-05	0.000186	CbGpPWpGaD
Clarithromycin—CYP2C19—Metabolism—PTGS1—esophageal cancer	2.52e-05	0.000186	CbGpPWpGaD
Clarithromycin—CYP1A2—Metabolism—GAPDH—esophageal cancer	2.49e-05	0.000184	CbGpPWpGaD
Clarithromycin—CYP2C19—Metabolism—PSME1—esophageal cancer	2.48e-05	0.000184	CbGpPWpGaD
Clarithromycin—CYP2C19—Metabolism—PSME2—esophageal cancer	2.48e-05	0.000184	CbGpPWpGaD
Clarithromycin—CYP1A2—Metabolism—CRABP1—esophageal cancer	2.47e-05	0.000183	CbGpPWpGaD
Clarithromycin—ABCB1—Metabolism—ENO1—esophageal cancer	2.46e-05	0.000182	CbGpPWpGaD
Clarithromycin—ABCB1—Metabolism—PTGS1—esophageal cancer	2.46e-05	0.000182	CbGpPWpGaD
Clarithromycin—ABCB1—Transmembrane transport of small molecules—CREBBP—esophageal cancer	2.45e-05	0.000182	CbGpPWpGaD
Clarithromycin—ABCB1—Metabolism—PSME1—esophageal cancer	2.42e-05	0.000179	CbGpPWpGaD
Clarithromycin—ABCB1—Metabolism—PSME2—esophageal cancer	2.42e-05	0.000179	CbGpPWpGaD
Clarithromycin—CYP3A4—Metabolism—ADH1B—esophageal cancer	2.41e-05	0.000178	CbGpPWpGaD
Clarithromycin—CYP3A5—Metabolism—HMOX1—esophageal cancer	2.37e-05	0.000176	CbGpPWpGaD
Clarithromycin—CYP1A2—Metabolism—GNG7—esophageal cancer	2.35e-05	0.000174	CbGpPWpGaD
Clarithromycin—CYP3A4—Metabolism—TYMP—esophageal cancer	2.3e-05	0.000171	CbGpPWpGaD
Clarithromycin—CYP3A5—Metabolism—ABCB1—esophageal cancer	2.28e-05	0.000169	CbGpPWpGaD
Clarithromycin—CYP3A4—Metabolism—CYP26A1—esophageal cancer	2.24e-05	0.000166	CbGpPWpGaD
Clarithromycin—CYP1A2—Metabolism—ALDH2—esophageal cancer	2.2e-05	0.000163	CbGpPWpGaD
Clarithromycin—CYP3A4—Metabolism—ALOX15—esophageal cancer	2.18e-05	0.000162	CbGpPWpGaD
Clarithromycin—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	2.17e-05	0.00016	CbGpPWpGaD
Clarithromycin—CYP2C19—Metabolism—CYP1B1—esophageal cancer	2.14e-05	0.000158	CbGpPWpGaD
Clarithromycin—CYP3A7—Metabolism—CREBBP—esophageal cancer	2.11e-05	0.000156	CbGpPWpGaD
Clarithromycin—CYP1A2—Metabolism—GSTT1—esophageal cancer	2.09e-05	0.000155	CbGpPWpGaD
Clarithromycin—ABCB1—Metabolism—CYP1B1—esophageal cancer	2.09e-05	0.000155	CbGpPWpGaD
Clarithromycin—CYP3A4—Metabolism—GSTO1—esophageal cancer	2.08e-05	0.000154	CbGpPWpGaD
Clarithromycin—CYP3A4—Metabolism—TPI1—esophageal cancer	2.08e-05	0.000154	CbGpPWpGaD
Clarithromycin—CYP1A2—Metabolism—CYP2A6—esophageal cancer	2.07e-05	0.000153	CbGpPWpGaD
Clarithromycin—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	2.06e-05	0.000153	CbGpPWpGaD
Clarithromycin—CYP2C19—Metabolism—CYP19A1—esophageal cancer	2.01e-05	0.000149	CbGpPWpGaD
Clarithromycin—CYP3A4—Metabolism—ALDOB—esophageal cancer	2e-05	0.000148	CbGpPWpGaD
Clarithromycin—ABCB1—Metabolism—CYP19A1—esophageal cancer	1.96e-05	0.000145	CbGpPWpGaD
Clarithromycin—CYP1A2—Metabolism—ENO1—esophageal cancer	1.96e-05	0.000145	CbGpPWpGaD
Clarithromycin—CYP1A2—Metabolism—PTGS1—esophageal cancer	1.96e-05	0.000145	CbGpPWpGaD
Clarithromycin—CYP1A2—Metabolism—PSME2—esophageal cancer	1.93e-05	0.000143	CbGpPWpGaD
Clarithromycin—CYP1A2—Metabolism—PSME1—esophageal cancer	1.93e-05	0.000143	CbGpPWpGaD
Clarithromycin—CYP3A4—Metabolism—GAPDH—esophageal cancer	1.92e-05	0.000142	CbGpPWpGaD
Clarithromycin—CYP3A4—Metabolism—CRABP1—esophageal cancer	1.9e-05	0.000141	CbGpPWpGaD
Clarithromycin—CYP3A7—Metabolism—NOS3—esophageal cancer	1.89e-05	0.00014	CbGpPWpGaD
Clarithromycin—CYP2C19—Metabolism—HMOX1—esophageal cancer	1.84e-05	0.000136	CbGpPWpGaD
Clarithromycin—CYP3A4—Metabolism—GNG7—esophageal cancer	1.81e-05	0.000134	CbGpPWpGaD
Clarithromycin—CYP2C19—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	1.8e-05	0.000133	CbGpPWpGaD
Clarithromycin—ABCB1—Metabolism—HMOX1—esophageal cancer	1.79e-05	0.000133	CbGpPWpGaD
Clarithromycin—CYP2C19—Metabolism—ABCB1—esophageal cancer	1.76e-05	0.00013	CbGpPWpGaD
Clarithromycin—CYP3A7—Metabolism—PTGS2—esophageal cancer	1.73e-05	0.000128	CbGpPWpGaD
Clarithromycin—CYP3A4—Metabolism—ALDH2—esophageal cancer	1.7e-05	0.000126	CbGpPWpGaD
Clarithromycin—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	1.69e-05	0.000125	CbGpPWpGaD
Clarithromycin—CYP1A2—Metabolism—CYP1B1—esophageal cancer	1.67e-05	0.000123	CbGpPWpGaD
Clarithromycin—CYP3A4—Metabolism—GSTT1—esophageal cancer	1.61e-05	0.00012	CbGpPWpGaD
Clarithromycin—CYP3A4—Metabolism—CYP2A6—esophageal cancer	1.6e-05	0.000118	CbGpPWpGaD
Clarithromycin—CYP1A2—Metabolism—CYP19A1—esophageal cancer	1.57e-05	0.000116	CbGpPWpGaD
Clarithromycin—CYP3A5—Metabolism—CREBBP—esophageal cancer	1.52e-05	0.000113	CbGpPWpGaD
Clarithromycin—CYP3A4—Metabolism—PTGS1—esophageal cancer	1.51e-05	0.000112	CbGpPWpGaD
Clarithromycin—CYP3A4—Metabolism—ENO1—esophageal cancer	1.51e-05	0.000112	CbGpPWpGaD
Clarithromycin—CYP3A4—Metabolism—PSME2—esophageal cancer	1.49e-05	0.00011	CbGpPWpGaD
Clarithromycin—CYP3A4—Metabolism—PSME1—esophageal cancer	1.49e-05	0.00011	CbGpPWpGaD
Clarithromycin—CYP3A7—Metabolism—EP300—esophageal cancer	1.44e-05	0.000106	CbGpPWpGaD
Clarithromycin—CYP1A2—Metabolism—HMOX1—esophageal cancer	1.43e-05	0.000106	CbGpPWpGaD
Clarithromycin—CYP1A2—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	1.4e-05	0.000104	CbGpPWpGaD
Clarithromycin—CYP1A2—Metabolism—ABCB1—esophageal cancer	1.37e-05	0.000102	CbGpPWpGaD
Clarithromycin—CYP3A5—Metabolism—NOS3—esophageal cancer	1.36e-05	0.000101	CbGpPWpGaD
Clarithromycin—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	1.33e-05	9.86e-05	CbGpPWpGaD
Clarithromycin—CYP3A4—Metabolism—CYP1B1—esophageal cancer	1.29e-05	9.53e-05	CbGpPWpGaD
Clarithromycin—CYP3A5—Metabolism—PTGS2—esophageal cancer	1.25e-05	9.24e-05	CbGpPWpGaD
Clarithromycin—CYP3A4—Metabolism—CYP19A1—esophageal cancer	1.21e-05	8.96e-05	CbGpPWpGaD
Clarithromycin—CYP2C19—Metabolism—CREBBP—esophageal cancer	1.18e-05	8.72e-05	CbGpPWpGaD
Clarithromycin—ABCB1—Metabolism—CREBBP—esophageal cancer	1.15e-05	8.51e-05	CbGpPWpGaD
Clarithromycin—CYP3A4—Metabolism—HMOX1—esophageal cancer	1.1e-05	8.17e-05	CbGpPWpGaD
Clarithromycin—CYP3A7—Metabolism—PIK3CA—esophageal cancer	1.06e-05	7.86e-05	CbGpPWpGaD
Clarithromycin—CYP3A4—Metabolism—ABCB1—esophageal cancer	1.06e-05	7.84e-05	CbGpPWpGaD
Clarithromycin—CYP2C19—Metabolism—NOS3—esophageal cancer	1.05e-05	7.81e-05	CbGpPWpGaD
Clarithromycin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	1.04e-05	7.69e-05	CbGpPWpGaD
Clarithromycin—CYP3A5—Metabolism—EP300—esophageal cancer	1.04e-05	7.68e-05	CbGpPWpGaD
Clarithromycin—ABCB1—Metabolism—NOS3—esophageal cancer	1.03e-05	7.62e-05	CbGpPWpGaD
Clarithromycin—CYP2C19—Metabolism—PTGS2—esophageal cancer	9.64e-06	7.14e-05	CbGpPWpGaD
Clarithromycin—ABCB1—Metabolism—PTGS2—esophageal cancer	9.41e-06	6.97e-05	CbGpPWpGaD
Clarithromycin—CYP1A2—Metabolism—CREBBP—esophageal cancer	9.17e-06	6.79e-05	CbGpPWpGaD
Clarithromycin—CYP1A2—Metabolism—NOS3—esophageal cancer	8.21e-06	6.08e-05	CbGpPWpGaD
Clarithromycin—CYP2C19—Metabolism—EP300—esophageal cancer	8.02e-06	5.94e-05	CbGpPWpGaD
Clarithromycin—ABCB1—Metabolism—EP300—esophageal cancer	7.83e-06	5.8e-05	CbGpPWpGaD
Clarithromycin—CYP3A5—Metabolism—PIK3CA—esophageal cancer	7.67e-06	5.68e-05	CbGpPWpGaD
Clarithromycin—CYP1A2—Metabolism—PTGS2—esophageal cancer	7.51e-06	5.56e-05	CbGpPWpGaD
Clarithromycin—CYP3A4—Metabolism—CREBBP—esophageal cancer	7.08e-06	5.24e-05	CbGpPWpGaD
Clarithromycin—CYP3A4—Metabolism—NOS3—esophageal cancer	6.34e-06	4.69e-05	CbGpPWpGaD
Clarithromycin—CYP1A2—Metabolism—EP300—esophageal cancer	6.25e-06	4.63e-05	CbGpPWpGaD
Clarithromycin—CYP2C19—Metabolism—PIK3CA—esophageal cancer	5.93e-06	4.39e-05	CbGpPWpGaD
Clarithromycin—CYP3A4—Metabolism—PTGS2—esophageal cancer	5.8e-06	4.29e-05	CbGpPWpGaD
Clarithromycin—ABCB1—Metabolism—PIK3CA—esophageal cancer	5.79e-06	4.29e-05	CbGpPWpGaD
Clarithromycin—CYP3A4—Metabolism—EP300—esophageal cancer	4.82e-06	3.57e-05	CbGpPWpGaD
Clarithromycin—CYP1A2—Metabolism—PIK3CA—esophageal cancer	4.62e-06	3.42e-05	CbGpPWpGaD
Clarithromycin—CYP3A4—Metabolism—PIK3CA—esophageal cancer	3.57e-06	2.64e-05	CbGpPWpGaD
